Related Experiment Video
Updated: Apr 23, 2026
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Totally Implantable Venous Access Devices and Duchenne Muscular Dystrophy: A Single Center Experience
Kaitlin Y Batley1, Zurisadai Gonzalez Castillo1, Kristy Riddle2
1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas.
Background:
Newly approved intravenous therapies for Duchenne muscular dystrophy (DMD) have led to unique challenges. Totally implantable venous access ports can be utilized to provide stable intravascular access but can be associated with procedural complications and long-term issues.
Methods:
Patients with DMD who underwent port placement between 2016 and 2024 were analyzed through chart review.
Results:
Thirty DMD patients with a total of 46 ports were identified. Twenty-one (70%) patients experienced at least one long-term complication, the most common being port malfunction in 11 (37%) patients. There were no procedural complications, but one patient experienced rhabdomyolysis 2 days after placement.
Conclusions:
We found that surgical placement of ports was safe in our patients with DMD but requires specific monitoring.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
01:29Cardiomyopathy V: Interprofessional Care
01:25Hemodialysis I: Introduction
01:30Cardiomyopathy II: Dilated Cardiomyopathy